» Articles » PMID: 28362421

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)

Overview
Journal J Vis Exp
Date 2017 Apr 1
PMID 28362421
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Diffuse Intrinsic Pontine Glioma (DIPG) is a childhood brainstem tumor that carries a universally fatal prognosis. Because surgical resection is not a viable treatment strategy and biopsy is not routinely performed, the availability of patient samples for research is limited. Consequently, efforts to study this disease have been challenged by a paucity of faithful disease models. To address this need, we describe here a protocol for the rapid processing of post-mortem autopsy tissue samples in order to generate durable patient-derived cell culture models that can be used in in vitro assays or in vivo orthotopic xenograft experiments. These models can be used to screen for potential drug targets and to study fundamental pathobiological processes within DIPG. This protocol can further be extended to analyze and isolate tumor and microenvironmental cells using Fluorescence-activated Cell Sorting (FACS), which enables subsequent analysis of gene expression, protein expression, or epigenetic modifications of DNA at the bulk cell or single cell level. Finally, this protocol can also be adapted to generate patient-derived cultures for other central nervous system tumors.

Citing Articles

Identifying adeno-associated virus (AAV) vectors that efficiently target high grade glioma cells, for in vitro monitoring of temporal cell responses.

Sarker F, Chen Y, Westhaus A, Lisowski L, ONeill G FEBS Open Bio. 2024; 14(11):1914-1925.

PMID: 39256894 PMC: 11532971. DOI: 10.1002/2211-5463.13894.


EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses.

Lertsumitkul L, Iliopoulos M, Wang S, McArthur S, Ebert L, Davenport A J Immunother Cancer. 2024; 12(8).

PMID: 39111833 PMC: 11308882. DOI: 10.1136/jitc-2024-009486.


The Landscape of Pediatric High-Grade Gliomas: The Virtues and Pitfalls of Pre-Clinical Models.

Furst L, Roussel E, Leung R, George A, Best S, Whittle J Biology (Basel). 2024; 13(6).

PMID: 38927304 PMC: 11200883. DOI: 10.3390/biology13060424.


DNA Methylation Profiles Are Stable in H3 K27M-Mutant Diffuse Midline Glioma Neurosphere Cell Lines.

Schniederjan M, Potnis C, Vasudevaraja V, Moser C, Watson B, Snuderl M Children (Basel). 2024; 11(4).

PMID: 38671709 PMC: 11049299. DOI: 10.3390/children11040492.


Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma.

Peterson E, Sajjakulnukit P, Scott A, Heaslip C, Andren A, Wilder-Romans K Cancer Metab. 2024; 12(1):11.

PMID: 38594734 PMC: 11003124. DOI: 10.1186/s40170-024-00341-7.


References
1.
Kieran M . Time to rethink the unthinkable: upfront biopsy of children with newly diagnosed diffuse intrinsic pontine glioma (DIPG). Pediatr Blood Cancer. 2014; 62(1):3-4. DOI: 10.1002/pbc.25266. View

2.
Wu G, Diaz A, Paugh B, Rankin S, Ju B, Li Y . The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet. 2014; 46(5):444-450. PMC: 4056452. DOI: 10.1038/ng.2938. View

3.
Sturm D, Bender S, Jones D, Lichter P, Grill J, Becher O . Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat Rev Cancer. 2014; 14(2):92-107. PMC: 4003223. DOI: 10.1038/nrc3655. View

4.
Fisher P, Breiter S, Carson B, Wharam M, Williams J, Weingart J . A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities. Cancer. 2000; 89(7):1569-76. DOI: 10.1002/1097-0142(20001001)89:7<1569::aid-cncr22>3.0.co;2-0. View

5.
Buczkowicz P, Hoeman C, Rakopoulos P, Pajovic S, Letourneau L, Dzamba M . Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet. 2014; 46(5):451-6. PMC: 3997489. DOI: 10.1038/ng.2936. View